Pregabalin
- Product NDC
- 73190-060
- Requested package NDC
- 73190-060-50
- 11-digit product format
- 731900060
- Labeler code
- 73190
- Product ID
- 73190-060_458708b4-56b8-8d18-e063-6294a90a8c47
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pregabalin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA212988
- Marketing category
- ANDA
- Marketing start
- 2025-12-09
- Substance
- PREGABALIN
- Active strength
- 300 mg/1
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212988-001 | PREGABALIN | PREGABALIN | 25MG | CAPSULE / ORAL | AB | 2022-03-08 | |
| A212988-002 | PREGABALIN | PREGABALIN | 50MG | CAPSULE / ORAL | AB | 2022-03-08 | |
| A212988-003 | PREGABALIN | PREGABALIN | 75MG | CAPSULE / ORAL | AB | 2022-03-08 | |
| A212988-004 | PREGABALIN | PREGABALIN | 100MG | CAPSULE / ORAL | AB | 2022-03-08 | |
| A212988-005 | PREGABALIN | PREGABALIN | 150MG | CAPSULE / ORAL | AB | 2022-03-08 | |
| A212988-006 | PREGABALIN | PREGABALIN | 200MG | CAPSULE / ORAL | AB | 2022-03-08 | |
| A212988-007 | PREGABALIN | PREGABALIN | 225MG | CAPSULE / ORAL | AB | 2022-03-08 | |
| A212988-008 | PREGABALIN | PREGABALIN | 300MG | CAPSULE / ORAL | AB | 2022-03-08 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A212988-001 | AB |
| A212988-002 | AB |
| A212988-003 | AB |
| A212988-004 | AB |
| A212988-005 | AB |
| A212988-006 | AB |
| A212988-007 | AB |
| A212988-008 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A212988-001 | PREGABALIN | 25MG | CAPSULE / ORAL | AB | 2022-03-08 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A212988-002 | PREGABALIN | 50MG | CAPSULE / ORAL | AB | 2022-03-08 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A212988-003 | PREGABALIN | 75MG | CAPSULE / ORAL | AB | 2022-03-08 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A212988-004 | PREGABALIN | 100MG | CAPSULE / ORAL | AB | 2022-03-08 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A212988-005 | PREGABALIN | 150MG | CAPSULE / ORAL | AB | 2022-03-08 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A212988-006 | PREGABALIN | 200MG | CAPSULE / ORAL | AB | 2022-03-08 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A212988-007 | PREGABALIN | 225MG | CAPSULE / ORAL | AB | 2022-03-08 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A212988-008 | PREGABALIN | 300MG | CAPSULE / ORAL | AB | 2022-03-08 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A212988-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A212988-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A212988-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A212988-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A212988-005 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A212988-006 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A212988-007 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A212988-008 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pregabalin | PREGABALIN | Proficient Rx LP | 189b610e-3e29-42fa-ab6e-73effbe0d054 | 2026-07-01 | Warnings, Adverse reactions | 212988 ANDA212988 |
| Pregabalin | PREGABALIN | Proficient Rx LP | 34846423-e747-42c5-9bcd-f99c557c4f67 | 2026-05-01 | Warnings, Adverse reactions | 212988 ANDA212988 |
| PREGABALIN | PREGABALIN | Eskayef Pharmaceuticals Limited | 65d9e751-61c2-4741-85c0-2526cfdc765c | 2025-12-31 | Warnings, Adverse reactions | 212988 ANDA212988 |
| Pregabalin | PREGABALIN | AvKARE | 458705af-06fa-57d1-e063-6394a90a3b2e | 2025-12-09 | Warnings, Adverse reactions | 212988 ANDA212988 73190-060-50 73190-060 73190006050 |
| Pregabalin | PREGABALIN | Westminster Pharmaceuticals, LLC | 6b0ee2cf-52c3-4052-bea0-1458a4233745 | 2025-10-31 | Warnings, Adverse reactions | 212988 ANDA212988 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pregabalin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| PREGABALIN | 300 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 55JG375S6M | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 458705af-06fa-57d1-e063-6394a90a3b2e | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 441d8579-bd15-4585-93f4-9de3db2d851d | Product name | 4 | 20251114 |
| 004d1029-ec13-fc89-74f4-3907cf5b6602 | Product name | 2 | 20140523 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73190-060-50 | Pregabalin | 500 in 1 BOTTLE | CAPSULE | 500 | 1 | |
| 73190-060-90 | Pregabalin | 90 in 1 BOTTLE | CAPSULE | 90 | 1 |
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 73190-060-50 | 73190006050 | 500 CAPSULE in 1 BOTTLE (73190-060-50) | 500 capsule | 2025-12-09 | No | No | Current |